StrainX Bioworks
PrivateLast Round
Series A
May 25, 2026
Total Funding Raised
$13M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
StrainX Bioworks operates in Healthcare & Life Sciences and is based in Bhopal. Its latest recorded funding round was a Series A round in May 2026.
StrainX Bioworks is a biotechnology company that uses synthetic biology and precision fermentation to develop sustainable, high-value biomolecules for the food, nutraceutical, and beauty industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clean Manufacturing, Fashion & Beauty, Sustainable Materials
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
StrainX Bioworks Comparables
Compare StrainX Bioworks with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cauldron | 81% | |
| Fermbox Bio | 79% | |
| Conagen | 79% |
For institutional investors. Book with your work email.
StrainX Bioworks Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
StrainX Bioworks Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Leo Capital | Series A |
| Good Startup | Series A |
| Dholakia Ventures | Series A |
| Prime Venture Partners | Series A |
| Sun Icon Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 30, 2026
Grew 48% QoQ, from 33 to 49 employees.
- Jul 16, 2026
Grew 26% QoQ, from 31 to 39 employees.
For institutional investors. Book with your work email.
StrainX Bioworks Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about StrainX Bioworks's valuation, stock price, and market status.
Is StrainX Bioworks a public or private company?
StrainX Bioworks is a private company.
What is the current stock price of StrainX Bioworks?
StrainX Bioworks is a private company, so its shares have no public market price. Caplight tracks StrainX Bioworks's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is StrainX Bioworks worth (valuation)?
Valuation information for StrainX Bioworks is not publicly available.
Can I buy StrainX Bioworks stock?
StrainX Bioworks shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was StrainX Bioworks's last funding round?
StrainX Bioworks's most recent funding round was Series A on May 25, 2026.
Who are the main investors in StrainX Bioworks?
Key investors in StrainX Bioworks include Leo Capital, Prime Venture Partners.
Will StrainX Bioworks IPO soon?
No public IPO plans have been announced for StrainX Bioworks.
How can I track StrainX Bioworks secondary market activity?
Caplight tracks bids, offers, and trades in StrainX Bioworks's shares on secondary markets.